Holen Sie sich die Stockscreener-App
79.80
1.47%
1.155
Schlusskurs vom Vortag:
$78.64
Offen:
$79.81
24-Stunden-Volumen:
1.22M
Relative Volume:
1.49
Marktkapitalisierung:
$2.77B
Einnahmen:
$635.89M
Nettoeinkommen (Verlust:
$171.92M
KGV:
18.31
EPS:
4.357
Netto-Cashflow:
$151.36M
1W Leistung:
-6.44%
1M Leistung:
-5.33%
6M Leistung:
-20.76%
1J Leistung:
-31.25%
1-Tages-Spanne:
$77.14
$80.85
1-Wochen-Bereich:
$77.14
$86.38
52-Wochen-Spanne:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
79.80 | 2.96B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
97.50 | 168.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TransMedics Group, Inc. (TMDX) Stock Forecasts - Yahoo Finance
TransMedics Group (TMDX), Why Is It Back In The Spotlight? - Simply Wall Street
Is TransMedics Group (NASDAQ:TMDX) Facing a Real Market Test? - Kalkine Media
TMDX5812024 Bond Profile: Coupon and Redemption - TradingView
TransMedics Group, Inc. (TMDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TransMedics CFO Fernando N. Araujo Files Initial SEC Ownership Disclosure Reporting No Shares - Kalkine Media
[Form 3] TransMedics Group, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Net margin % of TransMedics Group, Inc. – HAN:8T8 - TradingView
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? - Yahoo Finance
ETFs Investing in TransMedics Group, Inc. Stocks - TradingView
8T8 Forecast — Price Target — Prediction for 2027 - TradingView
A Look at TransMedics Group Inc (TMDX) After 3.0% Decline -- GF Value $159.18 vs Price $82.73 - GuruFocus
TransMedics offers a unique organ transplant te... - Pluang
TransMedics Offers Attractive Entry Point, With Upside Potential Outweighing Risks (TMDX) - Seeking Alpha
Investors urged to act on possible TransMedics leadership breaches and seek legal relief. - Pluang
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
Investors Purchase Large Volume of TransMedics Group Put Options (NASDAQ:TMDX) - MarketBeat
A Look at TransMedics Group Inc (TMDX) After 3.6% Decline -- GF Value $158.92 vs Price $83.90 - GuruFocus
(TMDX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX) - The Globe and Mail
Donald TrumpTRANSMEDICS GROUP INC Trump Trade on Jul. 08, 2026 - Quiver Quantitative
TransMedics Group, Inc. (TMDX) Stock Analysis: A 12.59% Potential Upside in the Revolutionary Organ Transplant Space - DirectorsTalk Interviews
TMDX Q2 2026 Earnings: EPS Misses Estimate as Shares Edge LowerDiluted EPS Report - careplusvn.com
An Organ Transplant Company With Its Own Fleet Of Aircraft – Insider Weekends (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group stock holds near model value as analysts stay positive - AD HOC NEWS
TransMedics Group, Inc.Common Stock (NQ: TMDX - The Chronicle-Journal
TransMedics Stock: Waiting On 2027 Catalysts (NASDAQ:TMDX) - Seeking Alpha
2 Stocks Down 28% and 34% to Buy and Hold - The Motley Fool
TransMedics Group, Inc. (TMDX) Presents at 2026 Global Healthcare ConferenceSlideshow - Seeking Alpha
TransMedics Group Jumps 6.5% Amid Sector-Wide Rally - AlphaStreet
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Buys 1,336 Shares of Stock - MarketBeat
Director buys TransMedics (TMDX) stock at $81.63 a share - Stock Titan
Weekly Recap: TMDX CFO appointment and TD Cowen $120 target - TradingView
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is TransMedics Group Inc (TMDX) a Bargain After 3.4% Drop? GF Value Says Undervalued - GuruFocus
TransMedics Slides After CFO Transition News Despite Reaffirmed 2026 Outlook - quiverquant.com
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.1%What's Next? - MarketBeat
Needham reiterates Buy on TransMedics stock, names new CFO By Investing.com - Investing.com UK
TransMedics (NASDAQ: TMDX) Appoints Fernando Araujo as CFO with $590K Base Salary - Kalkine Media
TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M. - Pluang
TransMedics Appoints Fernando Araujo as CFO with Detailed Compensation and Transition Plan - Kalkine Media
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook By Investing.com - Investing.com India
(TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M$757M, vs. FactSet Est of $743.1M - marketscreener.com
TransMedics Group, Inc. Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
TransMedics Group (NASDAQ:TMDX): Is the Market Too Cautious? - Kalkine Media
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook - PR Newswire
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why - Stocktwits
TransMedics Group (TMDX) Institutional Ownership 2026 - MarketBeat
TMDX Reiterated by TD Cowen -- Price Target Maintained at $120 - GuruFocus
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Option Exercise |
2.21 |
19,285 |
42,620 |
26,266 |
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
0.26%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):